Detalles de la búsqueda
1.
Phenomenon of tumor flare with talquetamab in a patient with extramedullary myeloma.
Haematologica
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385275
2.
Impact of race and ethnicity on early mortality in multiple myeloma: a SEER analysis.
Haematologica
; 2023 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37881838
3.
A Co-Management Model for Myeloid Malignancies That Evolved during the COVID-19 Pandemic.
Acta Haematol
; 146(2): 144-150, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36446346
4.
Epidemiology and survival trend of adult T-cell leukemia/lymphoma in the United States.
Cancer
; 126(3): 567-574, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31769871
5.
Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center.
Biol Blood Marrow Transplant
; 25(6): e199-e203, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30769194
6.
Associations between dermatologic immune-related adverse event morphologies and systemic immunomodulatory/immunosuppressive treatment: A large retrospective cohort study.
J Am Acad Dermatol
; 90(6): 1268-1271, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38341147
7.
A Retrospective Study of Adult Patients with Parry Romberg Syndrome.
Clin Exp Dermatol
; 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38699951
8.
Dercum's disease: A retrospective cohort study.
J Am Acad Dermatol
; 88(3): 738-741, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36228943
9.
Evaluating patterns of co-occurrence between cutaneous and noncutaneous immune-related adverse events after immune checkpoint inhibitor therapy.
J Am Acad Dermatol
; 88(1): 246-249, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35577231
10.
Morphologic characteristics of cutaneous immune-related adverse events in patients receiving immune checkpoint inhibitors combined with other anticancer therapies: A multicenter retrospective study.
J Am Acad Dermatol
; 88(2): 474-476, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35724890
11.
Development of multiple cutaneous immune-related adverse events among cancer patients after immune checkpoint blockade.
J Am Acad Dermatol
; 88(2): 485-487, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35738514
12.
Noncutaneous immune-related adverse events predict overall and progression-free survival in patients with cutaneous toxicities after immune checkpoint inhibitor therapy.
J Am Acad Dermatol
; 88(6): 1368-1370, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736625
13.
Dermatology evaluation for cutaneous immune-related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition.
J Am Acad Dermatol
; 88(3): 711-714, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36113616
14.
Tumor-infiltrating lymphocytes as a predictive biomarker of cutaneous immune-related adverse events after immune checkpoint blockade in patients with advanced melanoma.
J Am Acad Dermatol
; 89(1): 140-142, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36806644
15.
Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation.
Clin Exp Dermatol
; 48(9): 1058-1060, 2023 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171025
16.
Autologous stem cell transplantation in an older adult population.
Haematologica
; 107(9): 2261-2265, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35615933
17.
Association of pre-existing drug allergies with cutaneous immune-related adverse events among patients on immune checkpoint inhibitor therapy.
Br J Dermatol
; 187(3): 424-426, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290662
18.
Association between serum lactate dehydrogenase and cutaneous immune-related adverse events among patients on immune checkpoint inhibitors for advanced melanoma.
J Am Acad Dermatol
; 87(5): 1147-1149, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35192899
19.
Pharmacoeconomic analysis of palifermin to prevent mucositis among patients undergoing autologous hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant
; 20(6): 852-857, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24607557
20.
Improving Unrelated Donor Equity: Assessing Mismatched Donor Opportunities with Real-World Data in a Minority-Predominant Cohort.
Transplant Cell Ther
; 30(5): 544.e1-544.e8, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38417677